Neuropathy

Neuropathy, this term indicates damage or dysfunction of one or more nerves that typically results in numbness, tingling, muscle weakness and pain in the affected area. Neuropathy is mostly called as peripheral neuropathy. Peripheral nervous system is the network of nerves outside the brain and spinal cord. Neuropathy results when nerve cells, called neurons, are damaged or destroyed, as it disrupts the way the neurons communicate with each other and with the brain. Neuropathy can either affect one nerve (mononeuropathy) or nerve type, a combination of nerves in a limited area (multifocal neuropathy) or many peripheral nerves throughout the body (polyneuropathy).The peripheral nervous system is made up of three types of nerves, sensory nerves carry messages from the five senses (sight, hearing, smell, taste, touch) through the spinal cord to the brain. On the other hand motor nerves travel in the opposite direction of sensory nerves. They carry messages from brain to muscles. Motor nerves are responsible for movement coordination. Autonomic nerves are responsible for body functions by direct control, such as breathing, digestion, heart rate, blood pressure, sweating, bladder control and sexual arousal.

Health conditions that can cause peripheral neuropathy include

  • Autoimmune diseases
  • Diabetes
  • Infections
  • Inherited disorders
  • Tumors
  • Bone marrow disorders
  • Vitamin deficiencies
  • Brain and Spine injury

Sub-track

  • Diabetic neuropathy
  • Peripheral neuropathy
  • Cranial neuropathy
  • Autonomic neuropathy
  • Focal neuropathy

Market Analysis: According to the World Health Organization (WHO), it was estimated that there would be 285 million diabetics by 2010 in the world. This estimate is projected to increase by 65% to become 438 million in the year 2030. Thus, rising prevalence of diabetes mellitus is expected to increase the population of patients suffering from peripheral neuropathy. The global diabetic neuropathy market size was valued at USD 3.61 billion in 2018 and is projected to reach USD 7.12 billion by 2026, exhibiting a CAGR of 8.9% during the forecast period. By 2030, all of these cases are predicted to rise. The Diabetic Neuropathy Market is expected to grow at an annual rate of 8.9% till 2026. The market was valued USD 3.61 billion in 2018 and is expected to grow at an annual rate of 8.9% from 2019 to 2026. The global peripheral neuropathy market was worth US$ 1,470.9 million in 2016, and is predicted to grow at a CAGR of 3.2 percent from 2017 to 2025, reaching US$ 1,998.8 million.

ALSO READ Neurology Neurosurgery Neuroscience Neuropsychiatry Pain Disorder and Management Central Nervous System Pediatric Neurology Neuro-Oncology and Brain Tumors Neurophysiology Neuroimmunology Neuropathology Neuroimaging Neurodegenerative disease and Neurodegeneration Neurological Disorders Sleep Disorder Stroke Movement Disorders Parkinsons Disease Epilepsy Multiple Sclerosis Alzheimers Disease and Dementia Neuromuscular Disease Case Studies and Clinical Trials Novel Treatment Strategies Speech Disorders Demyelinating Disorders Cerebrovascular Disorders Autoimmune and Inflammatory Disorders Neuropathy Headache and Facial Pain Diagnosis and Screening of Neurological Disorders Neuropharmacology and Neurochemistry Stem Cells and Neuroregeneration Cognitive Neuroscience Motor System Disorders Behavioral Neurology Computational Neuroscience Neurogenetics Spinal Neurosurgery Pediatric Neurosurgery Stereotactic and Functional Neurosurgery Neurovascular Surgery Intraoperative Neurophysiology Peripheral Nerve Surgery Robotics in Neurosurgery Latest advancement in Brain Surgery Skull Base Surgery Trauma and Critical Care Child Psychology Social Cognitive Neuroscience Neurophysics Neuroradiology Neurorobotics Advanced Imaging Techniques Personalized Medicine Neuroinformatics Gene Therapy Neural Interface and Brain-Computer Interface BCI Neurorehabilitation Regenerative Medicine and Stem Cell Therapy Telemedicine in Neurology Nano-Neuroscience Neurosurgical Innovations Neuroethics Precision Psychiatry Neuromodulation and New Therapeutic Approaches Microbiome and Neurological Health Neurological Implications of COVID-19

Tags
Neurology Conferences 2024 USA Neuroscience Conferences 2024 Dubai Alzheimer's Disease Conferences Neurology Conferences Parkinson Disease Conferences Neurology Conferences 2024 Asia Neurophysiology Conferences CNS Conferences Neurology Conferences 2024 Europe Dementia Conferences Neurology Conferences Europe Neurosurgery Conferences 2024 Neurology Conferences 2024 Neurology Conferences 2024 Japan Sleep Disorders Conferences

+1-778-244-7702